SCHEMBL345344

SCHEMBL345344

CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(C)C

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.55
TSHR P16473 1/20 0.53
THRB P10828 1/20 0.53
LMNA P02545 2/20 0.53
DNM1 Q05193 2/20 0.50
SPHK1 Q9NYA1 1/20 0.50
ADH1B P00325 1/20 0.46
ADH1C P00326 1/20 0.46
ADH1A P07327 1/20 0.46
ADH4 P08319 1/20 0.46
ADH7 P40394 1/20 0.46
PLA2G1B P04054 1/20 0.46
PLA2G2A P14555 1/20 0.46
ACE2 Q9BYF1 1/20 0.44
FDPS P14324 3/20 0.44
GPR84 Q9NQS5 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3002559 1.00 OPRM1 (0.55) OPRM1TSHRTHRBLMNADNM1
SCHEMBL3223191 1.00 OPRM1 (0.55) OPRM1TSHRTHRBLMNADNM1
SCHEMBL671913 1.00 OPRM1 (0.55) OPRM1TSHRTHRBLMNADNM1
SCHEMBL6122664 1.00 OPRM1 (0.55) OPRM1TSHRTHRBLMNADNM1
SCHEMBL15148 1.00 OPRM1 (0.55) OPRM1TSHRTHRBLMNADNM1
SCHEMBL157759 1.00 OPRM1 (0.55) OPRM1TSHRTHRBLMNADNM1
Hexadecane SCHEMBL23000686 1.00 OPRM1 (0.55) OPRM1TSHRTHRBLMNADNM1
SCHEMBL344997 1.00 OPRM1 (0.55) OPRM1TSHRTHRBLMNADNM1
Octane SCHEMBL7455770 1.00 OPRM1 (0.55) OPRM1TSHRTHRBLMNADNM1
SCHEMBL22950680 1.00 OPRM1 (0.55) OPRM1TSHRTHRBLMNADNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 263 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8603503-B2 Biliquid foams stable dispersions thereof and a corresponding process of manufacturing DRUG DELIVERY SOLUTIONS LIMITED (GB) 2013-12-10 US claimed
EP-1656121-B1 BILIQUID FOAMS, STABLE DISPERSIONS THEREOF AND A CORRESPONDING PROCESS OF MANUFACTURING DRUG DELIVERY SOLUTIONS LTD (GB) 2013-01-16 EP claimed
US-20060239947-A1 Biliquid foams stable dispersions thereof and a corresponding process of manufacturing DRUG DELIVERY SOLUTIONS LIMITED (GB) 2006-10-26 US claimed
EP-1656121-A1 BILIQUID FOAMS, STABLE DISPERSIONS THEREOF AND A CORRESPONDING PROCESS OF MANUFACTURING Drug Delivery Solutions Limited (GB) 2006-05-17 EP claimed
WO-2005011643-A1 BILIQUID FOAMS, STABLE DISPERSIONS THEREOF AND A CORRESPONDING PROCESS OF MANUFACTURING DRUG DELIVERY SOLUTIONS LIMITED (GB) 2005-02-10 WO claimed
US-6319491-B1 COMPOSITION COMPRISING DENATURED ETHYL ALCOHOL, HYDROPHOBIC SILICA, MONOETHYL ESTER OF COPOLYMER OF METHYL VINYL ETHER AND MALEIC ANHYDRIDE, ISO-OCTAHEXACONTANE, OCTAMETHYLCYCLOTETRASILOXANE AND HYDROXYPROPYL CELLUOSE WHIPPLE MICHAEL B (US) 2001-11-20 US claimed
EP-1051149-A1 COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2000-11-15 EP claimed
WO-1999038485-A1 COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1999-08-05 WO claimed
WO-1999038486-A1 COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1999-08-05 WO claimed
US-5919467-A BRANCHED CHAIN ALIPHATIC HYDROCARBON, POLYETHYLENE PARTICLES, CROSSLINKED ACRYLATE POLYMER, ALKYLMETHYLSILOXANE THE PROCTOR & GAMBLE COMPANY (US) 1999-07-06 US claimed
EP-0785763-A4 1997-07-30 EP claimed
EP-0785763-A1 POWDER COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1997-07-30 EP claimed
EP-0752845-A4 POWDER COSMETIC COMPOSITIONS PROCTER & GAMBLE (US) 1997-03-19 EP claimed
EP-0752845-A1 POWDER COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1997-01-15 EP claimed
WO-1996015761-A1 COSMETIC COMPOSITIONS IN STICK FORM THE PROCTER & GAMBLE COMPANY (US) 1996-05-30 WO claimed
WO-1996015760-A1 COSMETIC COMPOSITIONS IN STICK FORM THE PROCTER & GAMBLE COMPANY (US) 1996-05-30 WO claimed
WO-1996015762-A1 COSMETIC COMPOSITIONS IN STICK FORM THE PROCTER & GAMBLE COMPANY (US) 1996-05-30 WO claimed
WO-1995025503-A1 POWDER COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1995-09-28 WO claimed
WO-1995025499-A1 POWDER COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1995-09-28 WO claimed
EP-3131530-B1 VOLUMIZING MASCARA COMPOSITIONS AVON PROD INC (US) 2021-09-22 EP disclosed
US-20210236403-A1 COSMETIC, PERSONAL CARE, AND CLEANING PRODUCTS Planet Lindsay, LLC (US) 2021-08-05 US disclosed
US-10682383-B2 Personal care compositions with improved hyposensitivity THE PROCTER & GAMBLE COMPANY (US) 2020-06-16 US disclosed
US-10532010-B2 Volumizing mascara compositions AVON PRODUCTS, INC. (US) 2020-01-14 US disclosed
US-20190111095-A1 Personal Care Compositions With Improved Hyposensitivity PROCTER & GAMBLE (US) 2019-04-18 US disclosed
US-10183051-B2 Personal care compositions with improved hyposensitivity THE PROCTER & GAMBLE COMPANY (US) 2019-01-22 US disclosed
EP-2968105-B1 COSMETIC COMPOSITIONS HAVING PERSISTENT TIGHTENING EFFECTS AVON PROD INC (US) 2017-06-14 EP disclosed
US-20170128512-A1 Personal Care Compositions With Improved Hyposensitivity PROCTER & GAMBLE (US) 2017-05-11 US disclosed
US-9585866-B2 Personal care compositions with improved hyposensitivity THE PROCTER & GAMBLE COMPANY (US) 2017-03-07 US disclosed
EP-1747240-B1 CONDITIONING/STYLING TETRAPOLYMERS ISP INVESTMENTS INC (US) 2016-07-27 EP disclosed
US-20160136082-A1 Cosmetic Compositions Having Persistent Tightening Effects AVON PRODUCTS, INC. (US) 2016-05-19 US disclosed
US-9271921-B2 Cosmetic compositions having persistent tightening effects AVON PRODUCTS, INC. (US) 2016-03-01 US disclosed
EP-2968105-A1 COSMETIC COMPOSITIONS HAVING PERSISTENT TIGHTENING EFFECTS Avon Products, Inc. (US) 2016-01-20 EP disclosed
US-20150297473-A1 Volumizing Mascara Compositions AVON PRODUCTS, INC. 2015-10-22 US disclosed
US-9084734-B2 Peptide personal care compositions and methods for their use DANISCO US INC. (US) 2015-07-21 US disclosed
EP-1666021-B1 Personal care compositions with improved hyposensitivity PROCTER & GAMBLE (US) 2015-07-01 EP disclosed
US-20150174094-A1 Personal Care Compositions With Improved Hyposensitivity PROCTER & GAMBLE (US) 2015-06-25 US disclosed
US-20150152404-A1 PROTEASES PRODUCING AN ALTERED IMMUNOLOGICAL RESPONSE AND METHODS OF MAKING AND USING THE SAME DANISCO US INC (US) 2015-06-04 US disclosed
US-9006169-B2 Personal care compositions with improved hyposensitivity THE PROCTER & GAMBLE COMPANY (US) 2015-04-14 US disclosed
US-8962796-B2 Modified variant Bowman Birk protease inhibitors DANISCO US INC. (US) 2015-02-24 US disclosed
US-20140329736-A1 Personal Care Compositions with Improved Hyposensitivity THE PROCTER & GAMBLE COMPANY (US) 2014-11-06 US disclosed
US-20140294881-A1 PROTEASES PRODUCING AN ALTERED IMMUNOLOGICAL RESPONSE AND METHODS OF MAKING AND USING THE SAME DANISCO US INC. (US) 2014-10-02 US disclosed
WO-2014143376-A1 COSMETIC COMPOSITIONS HAVING PERSISTENT TIGHTENING EFFECTS AVON PRODUCTS, INC. (US) 2014-09-18 WO disclosed
EP-1610807-B1 PERSONAL CARE COMPOSITIONS COMPRISING REPEAT SEQUENCE PROTEIN POLYMERS FROM SILK AND ELASTIN DANISCO US INC (US) 2014-07-30 EP disclosed
US-20140186922-A1 PROTEASES PRODUCING AN ALTERED IMMUNOGENIC RESPONSE AND METHODS OF MAKING AND USING THE SAME DANISCO US INC. (US) 2014-07-03 US disclosed
US-8603503-B2 Biliquid foams stable dispersions thereof and a corresponding process of manufacturing DRUG DELIVERY SOLUTIONS LIMITED (GB) 2013-12-10 US disclosed
US-8551508-B2 Cosmetic, personal care, cleaning agent, and nutritional supplement compositions and methods of making and using same SCHOTT AG (DE) 2013-10-08 US disclosed
US-20130216519-A1 PROTEASES PRODUCING AN ALTERED IMMUNOGENIC RESPONSE AND METHODS OF MAKING AND USING THE SAME DANISCO US INC. (US) 2013-08-22 US disclosed
US-20130202546-A1 Cosmetic Compositions Having Persistent Tightening Effects AVON PRODUCTS, INC. (US) 2013-08-08 US disclosed
US-20130195781-A1 Modified Variant Bowman Birk Protease Inhibitors DANISCO US INC. (US) 2013-08-01 US disclosed
US-8455417-B2 Personal care compositions with improved hyposensitivity THE PROCTER & GAMBLE COMPANY (US) 2013-06-04 US disclosed
US-20130065829-A1 PEPTIDES AND SUPPORTED PEPTIDES FOR TREATING SKIN DISEASES DANISCO US INC. (US) 2013-03-14 US disclosed
US-8394941-B2 Modified variant Bowman Birk Protease Inhibitors DANISCO US INC. (US) 2013-03-12 US disclosed
US-20130059772-A1 Use of Repeat Sequence Protein Polymers in Personal Care Compositions DANISCO US INC. (US) 2013-03-07 US disclosed
EP-1656121-B1 BILIQUID FOAMS, STABLE DISPERSIONS THEREOF AND A CORRESPONDING PROCESS OF MANUFACTURING DRUG DELIVERY SOLUTIONS LTD (GB) 2013-01-16 EP disclosed
US-20120276021-A1 USE OF REPEAT SEQUENCE PROTEIN POLYMERS IN PERSONAL CARE COMPOSITIONS DANISCO US INC. (US) 2012-11-01 US disclosed
US-20120270932-A1 Personal Care Compositions with Improved Hyposensitivity CAHEN CHRISTINE MARIE (GB) 2012-10-25 US disclosed
US-8273704-B2 Cosmetics; increase skin fibroblast viability; amino acid sequences DANISCO US INC. (US) 2012-09-25 US disclosed
EP-1549286-B1 COSMETIC COMPOSITIONS WITH REDUCED TACK PROCTER & GAMBLE (US) 2012-07-04 EP disclosed
US-20120014885-A1 Personal Care Compositions and Methods for Their Use DANISCO US INC. 2012-01-19 US disclosed
CN-102245635-A Modified variant bowman birk protease inhibitors DANISCO US INC GENENCOR DIV 2011-11-16 CN disclosed
US-8048859-B2 Use of repeat sequence protein polymers in personal care compositions DANISCO US INC. (US) 2011-11-01 US disclosed
EP-1692158-B1 VEGF BINDING AND SUPPORTED PEPTIDES FOR TREATING SKIN DISEASES DANISCO US INC (US) 2011-10-26 EP disclosed
US-20110256608-A1 Modified Variant Bowman Birk Protease Inhibitors DANISCO US INC. (US) 2011-10-20 US disclosed
EP-1373296-B1 PROTEINS PRODUCING AN ALTERED IMMUNOGENIC RESPONSE AND METHODS OF MAKING AND USING THE SAME GENENCOR INT (US) 2011-10-05 EP disclosed
CN-101278051-B Personal care compositions and methods of use thereof GENENCOR INT 2011-10-05 CN disclosed
US-20110230405-A1 Peptides and Supported Peptides for Treating Skin Diseases GENENCOR INTERNATIONAL, INC. 2011-09-22 US disclosed
EP-2344531-A1 MODIFIED VARIANT BOWMAN BIRK PROTEASE INHIBITORS Danisco US Inc. (US) 2011-07-20 EP disclosed
EP-1837054-B1 Cosmetic composition comprising seabuckthorn PROCTER & GAMBLE (US) 2011-06-29 EP disclosed
US-7947475-B2 Modified variant Bowman Birk protease inhibitors DANISCO US INC. (US) 2011-05-24 US disclosed
US-20110076260-A1 Proteases Producing an Altered Immunogenic Response and Methods of Making and Using the Same GENENCOR INTERNATIONAL, INC. 2011-03-31 US disclosed
EP-1481664-B1 Stable cosmetic compositions comprising a self-tanning agent PROCTER & GAMBLE (US) 2010-12-22 EP disclosed
US-7846424-B2 Non-pressurized post-application expanding composition AVON PRODUCTS, INC (US) 2010-12-07 US disclosed
EP-1692160-B1 FGF-5 BINDING AND SUPPORTED PEPTIDES DANISCO US INC (US) 2010-10-27 EP disclosed
EP-1692159-B1 TGF-BETA1 BINDING AND SUPPORTED PEPTIDES DANISCO US INC (US) 2010-09-29 EP disclosed
US-7803902-B2 comprise peptides that bind target proteins, and that are further modified to have greater protease inhibitory activity and/or be produced at greater yields than the unmodified BBPIs; has a greater trypsin inhibitory activity; used in personal care DANISCO US INC. (US) 2010-09-28 US disclosed
US-20100221780-A1 comprise peptides that bind target proteins, and that are further modified to have greater protease inhibitory activity and/or be produced at greater yields than the unmodified BBPIs; has a greater trypsin inhibitory activity DANISCO US INC. (US) 2010-09-02 US disclosed
US-7772181-B2 Personal care compositions comprising modified variant Bowman Birk Protease Inhibitors DANISCO US INC. (US) 2010-08-10 US disclosed
WO-2010044786-A1 MODIFIED VARIANT BOWMAN BIRK PROTEASE INHIBITORS DANISCO US INC., GENENCOR DIVISION (US) 2010-04-22 WO disclosed
US-20100092409-A1 PERSONAL CARE COMPOSITIONS COMPRISING MODIFIED VARIANT BOWMAN BIRK PROTEASE INHIBITORS DANISCO US INC. 2010-04-15 US disclosed
US-20100093028-A1 comprise peptides that bind target proteins, and that are further modified to have greater protease inhibitory activity and/or be produced at greater yields than the unmodified BBPIs; has a greater trypsin inhibitory activity; used in personal care DANISCO US INC. 2010-04-15 US disclosed
EP-1280952-B1 WET WIPES COMPRISING ION-SENSITIVE, WATER-DISPERSIBLE POLYMERS AND METHODS OF MAKING SAME KIMBERLY CLARK CO (US) 2010-04-07 EP disclosed
EP-1530637-B1 SUBTILISIN CARLSBERG PROTEINS WITH REDUCED IMMUNOGENICITY GENENCOR INT (US) 2010-02-10 EP disclosed
US-20090280071-A1 USE OF REPEAT SEQUENCE PROTEIN POLYMERS IN PERSONAL CARE COMPOSITIONS GENENCOR INTERNATIONAL, INC. 2009-11-12 US disclosed
EP-1493430-B1 Self-tanning compositions comprising a water-soluble vitamin B3 compound and an alpha-hydroxycarbonyl self-tanning agent PROCTER & GAMBLE (US) 2009-11-11 EP disclosed
CN-101575635-A Subtilisin carlsberg proteins with reduced immunogenicity GENECOR INT INC (US) 2009-11-11 CN disclosed
CN-100556395-C Non-pressurized post-application expanding compositions AVON PROD INC (US) 2009-11-04 CN disclosed
EP-2106257-A2 COMPOSITIONS FOR PROVIDING COLOR TO ANIMATE OBJECTS AND RELATED METHODS PPG Industries Ohio, Inc. (US) 2009-10-07 EP disclosed
EP-1280951-B1 TRIGGERABLE POLYMER COMPOSITION, AND ITEMS USING SAME KIMBERLY CLARK CO (US) 2009-07-08 EP disclosed
US-20090162917-A1 Subtilism Carlsberg Proteins With Reduced Immunogencity HARDING FIONA A 2009-06-25 US disclosed
US-7524816-B2 Peptides and supported peptides for treating skin diseases GENENCOR INTERNATIONAL, INC. (US) 2009-04-28 US disclosed
WO-2009050642-A2 COSMETIC COMPOSITION COMPRISING SOLID ENTRAPPING PARTICLES FOR SUSTAINED RELEASE OF VOLATILE MATERIALS THE PROCTER & GAMBLE COMPANY (US) 2009-04-23 WO disclosed
EP-2050433-A1 Cosmetic composition comprising solid entrapping particles for sustained release of volatile materials The Procter and Gamble Company (US) 2009-04-22 EP disclosed
US-20090098170-A1 COSMETIC COMPOSITION COMPRISING SOLID ENTRAPPING PARTICLES FOR SUSTAINED RELEASE OF VOLATILE MATERIALS THE PROCTER & GAMBLE COMPANY 2009-04-16 US disclosed
US-20090060933-A1 PROTEASES PRODUCING AN ALTERED IMMUNOGENIC RESPONSE AND METHODS OF MAKING AND USING THE SAME ESTELL DAVID A 2009-03-05 US disclosed
US-7485618-B2 FGF-5 supported and binding peptides GENENCOR INTERNATIONAL, INC. (US) 2009-02-03 US disclosed
US-7476528-B2 Proteins producing an altered immunogenic response and methods of making and using the same GENENCOR INTERNATIONAL, INC. (US) 2009-01-13 US disclosed
EP-1997476-A1 Hair thickening composition and method Sebastian International, INC (US) 2008-12-03 EP disclosed
US-20080269139-A1 FGF-5 Supported and Binding Peptides GENENCOR INTERNATIONAL, INC. 2008-10-30 US disclosed
CN-101278051-A Personal care compositions and methods of use thereof GENENCOR INT (US) 2008-10-01 CN disclosed
US-20080226706-A1 Use of Repeat Sequence Protein Polymers in Personal Care Compositions GENENCOR INTERNATIONAL, INC. 2008-09-18 US disclosed
WO-2008091916-A2 COMPOSITIONS FOR PROVIDING COLOR TO ANIMATE OBJECTS AND RELATED METHODS PPG INDUSTRIES OHIO, INC. (US) 2008-07-31 WO disclosed
US-7390478-B2 Hair thickening composition and method Sebastian International, Inc. (US) 2008-06-24 US disclosed
WO-2008070368-A2 METHODS AND COMPOSITIONS FOR SKIN CARE LIVING PROOF, INC. (US) 2008-06-12 WO disclosed
US-7378083-B2 Stable cosmetic composition comprising a self-tanning agent THE PROCTER & GAMBLE COMPANY (US) 2008-05-27 US disclosed
US-20080113917-A1 Tgfbeta Supported and Binding Peptides DANISCO US INC. 2008-05-15 US disclosed
US-20080112909-A1 COMPOSITIONS FOR PROVIDING COLOR TO ANIMATE OBJECTS AND RELATED METHODS PPG INDUSTRIES OHIO, INC. (US) 2008-05-15 US disclosed
EP-1411806-B1 PRE-MOISTENED WIPE PRODUCT KIMBERLY CLARK CO (US) 2008-03-19 EP disclosed
US-7332320-B2 Protease producing an altered immunogenic response and methods of making and using the same GENENCOR INTERNATIONAL, INC. (US) 2008-02-19 US disclosed
EP-1886700-A2 Ion-sensitive, water dispersible polymers, a method of making same and items using same Kimberly-Clark Worldwide, Inc. (US) 2008-02-13 EP disclosed
US-7326406-B2 Dual component skin care compositions that comprise a self-tanning agent THE PROCTER & GAMBLE COMPANY (US) 2008-02-05 US disclosed
US-7326405-B2 Cosmetic compositions THE PROCTER & GAMBLE COMPANY (US) 2008-02-05 US disclosed
EP-1880007-A2 PERSONAL CARE COMPOSITIONS AND METHODS FOR THEIR USE GENENCOR INTERNATIONAL, INC. (US) 2008-01-23 EP disclosed
EP-1278557-B1 ION-SENSITIVE, WATER DISPERSIBLE POLYMERS KIMBERLY CLARK CO (US) 2007-12-19 EP disclosed
US-20070275021-A1 NEW COSMETIC, PERSONAL CARE, CLEANING AGENT, AND NUTRITIONAL SUPPLEMENT COMPOSITIONS AND METHODS OF MAKING AND USING SAME SCHOTT AG (DE) 2007-11-29 US disclosed
US-7297678-B2 Use of repeat sequence protein polymers in personal care compositions GENENCOR INTERNATIONAL, INC. (US) 2007-11-20 US disclosed
EP-1839641-A1 Cosmetic composition comprising botanical extracts and a thickener The Procter & Gamble Company (US) 2007-10-03 EP disclosed
US-7276459-B1 Ion-sensitive, water-dispersible polymers, a method of making same and items using same KIMBERLY-CLARK WORLDWIDE, INC. (US) 2007-10-02 US disclosed
WO-2007107914-A1 COSMETIC COMPOSITION COMPRISING GINGKO BILOBA AND SUNSCREEN AGENTS THE PROCTER & GAMBLE COMPANY (US) 2007-09-27 WO disclosed
US-20070224138-A1 Cosmetic composition comprising gingko biloba and sunscreen agents THE PROCTOR & GAMBLE COMPANY 2007-09-27 US disclosed
WO-2007107913-A2 COSMETIC COMPOSITION COMPRISING SEABUCKTHORN THE PROCTER & GAMBLE COMPANY (US) 2007-09-27 WO disclosed
US-20070224229-A1 Cosmetic composition comprising Seabuckthorn THE PROCTER & GAMBLE COMPANY 2007-09-27 US disclosed
EP-1837054-A1 Cosmetic composition comprising seabuckthorn The Procter and Gamble Company (US) 2007-09-26 EP disclosed
EP-1837053-A1 Cosmetic composition comprising gingko biloba and sunscreen agents The Procter and Gamble Company (US) 2007-09-26 EP disclosed
US-7250174-B2 As preservative SCHOTT AG (DE) 2007-07-31 US disclosed
EP-1373296-A4 PROTEINS PRODUCING AN ALTERED IMMUNOGENIC RESPONSE AND METHODS OF MAKING AND USING THE SAME GENENCOR INT (US) 2007-03-28 EP disclosed
EP-1530637-A4 SUBTILISIN CARLSBERG PROTEINS WITH REDUCED IMMUNOGENICITY GENENCOR INT (US) 2007-03-21 EP disclosed
WO-2006121610-A2 PERSONAL CARE COMPOSITIONS AND METHODS FOR THEIR USE GENENCOR INTERNATIONAL, INC. (US) 2006-11-16 WO disclosed
US-20060239947-A1 Biliquid foams stable dispersions thereof and a corresponding process of manufacturing DRUG DELIVERY SOLUTIONS LIMITED (GB) 2006-10-26 US disclosed
EP-1493429-B1 Dual component skin care compositions that comprise a self-tanning agent PROCTER & GAMBLE (US) 2006-09-06 EP disclosed
US-7101612-B2 Pre-moistened wipe product KIMBERLY CLARK WORLDWIDE, INC. (US) 2006-09-05 US disclosed
EP-1692158-A2 TGF-BETA BINDING AND SUPPORTED PEPTIDES GENENCOR INTERNATIONAL, INC. (US) 2006-08-23 EP disclosed
EP-1692159-A2 TGF-BETA BINDING AND SUPPORTED PEPTIDES GENENCOR INTERNATIONAL, INC. (US) 2006-08-23 EP disclosed
EP-1692160-A2 FGF-5 BINDING AND SUPPORTED PEPTIDES GENENCOR INTERNATIONAL, INC. (US) 2006-08-23 EP disclosed
US-20060147399-A1 Non-pressurized post-application expanding composition CITIBANK, N.A., LONDON BRANCH 2006-07-06 US disclosed
EP-1666021-A1 Personal care compositions with improved hyposensitivity THE PROCTER & GAMBLE COMPANY (US) 2006-06-07 EP disclosed
EP-1656121-A1 BILIQUID FOAMS, STABLE DISPERSIONS THEREOF AND A CORRESPONDING PROCESS OF MANUFACTURING Drug Delivery Solutions Limited (GB) 2006-05-17 EP disclosed
US-20060093571-A1 Hair and skin protecting compositions based on esters or ethers of betulin GLINSKI JAN 2006-05-04 US disclosed
US-20060088486-A1 Topical use of post-application expanding cosmetic composition AVON PRODUCTS, INC. 2006-04-27 US disclosed
EP-1272144-A4 NEW COSMETIC, PERSONAL CARE, CLEANING AGENT, AND NUTRITIONAL SUPPLEMENT COMPOSITIONS COMPRISING BIOACTIVE GLASS AND METHODS OF MAKING AND USING THE SAME SCHOTT AG (DE) 2006-04-26 EP disclosed
CN-1246517-C Ion-sensitive water-dispersible polymers, method of making same and product using same KIMBERLY CLARK CO (US) 2006-03-22 CN disclosed
WO-2006014447-A1 PERSONAL CARE COMPOSITIONS WITH IMPROVED HYPOSENSITIVITY THE PROCTER & GAMBLE COMPANY (US) 2006-02-09 WO disclosed
EP-1554378-A4 PROTEASES PRODUCING AN ALTERED IMMUNOGENIC RESPONSE AND METHODS OF MAKING AND USING THE SAME GENENCOR INT (US) 2006-01-11 EP disclosed
US-20060002868-A1 Coloring skin with a mixture of a water-soluble vitamin B3 compound and an alpha-hydroxyaldehyde self-tanning agent (dihydroxyacetone, erythrulose); more even skin coloring THE PROCTER & GAMBLE COMPANY 2006-01-05 US disclosed
US-20060002876-A1 Personal care compositions with improved hyposensitivity THE PROCTER & GAMBLE COMPANY 2006-01-05 US disclosed
EP-1610807-A2 USE OF REPEAT SEQUENCE PROTEIN POLYMERS IN PERSONAL CARE COMPOSITIONS Dow Corning Corporation (US) 2006-01-04 EP disclosed
EP-1609460-A1 Skin care compositions comprising fatty material having a melting temperature range of 21-40 C THE PROCTER & GAMBLE COMPANY (US) 2005-12-28 EP disclosed
CN-1703196-A Non-pressurized post-application expanding compositions AVON PROD INC (US) 2005-11-30 CN disclosed
CN-1703511-A Subtilisin carlsberg proteins with reduced immunogenicity GENENCOR INT (US) 2005-11-30 CN disclosed
EP-1005322-B1 WEAR RESISTANT COSMETICS AVON PROD INC (US) 2005-11-09 EP disclosed
US-20050238607-A1 FGF-5 supported and binding peptides GENECORE INTERNATIONAL, INC. 2005-10-27 US disclosed
US-20050239043-A1 Subtilisin carlsberg proteins with reduced immunogenicity GENENCOR INERNATIONAL, INC. 2005-10-27 US disclosed
WO-2005094868-A1 USE OF REPEAT SEQUENCE PROTEIN POLYMERS IN PERSONAL CARE COMPOSITIONS GENENCOR INTERNATIONAL, INC. (US) 2005-10-13 WO disclosed
US-20050202552-A1 Proteins producing an altered immunogenic response and methods of making and using the same ESTELL DAVID A (US) 2005-09-15 US disclosed
US-20050202551-A1 Proteins producing an altered immunogenic response and methods of making and using the same ESTELL DAVID A (US) 2005-09-15 US disclosed
US-20050203026-A1 Rosacea; vascular endothelial growth factor inhibitors; protease inhibitors such as Bowman-Birk Inhibitor, soybean trypsin inhibitor, and Eglin chymotrypsin inhibitor DANISCO US INC. 2005-09-15 US disclosed
US-20050186164-A1 Hair thickening composition and method Sebastian International, Inc. 2005-08-25 US disclosed
EP-1566162-A1 Hair Thickening compositon and method Sebastian International, INC (US) 2005-08-24 EP disclosed
US-6929939-B2 Proteins producing an altered immunogenic response and methods of making and using the same GENENCOR INTERNATIONAL, INC. (US) 2005-08-16 US disclosed
EP-1554378-A2 PROTEASES PRODUCING AN ALTERED IMMUNOGENIC RESPONSE AND METHODS OF MAKING AND USING THE SAME GENENCOR INTERNATIONAL, INC. (US) 2005-07-20 EP disclosed
US-20050148059-A1 Protease producing an altered immunogenic response and methods of making and using the same GENENCOR INTERNATIONAL, INC. 2005-07-07 US disclosed
EP-1549286-A1 COSMETIC COMPOSITIONS WITH REDUCED TACK THE PROCTER & GAMBLE COMPANY (US) 2005-07-06 EP disclosed
US-20050142094-A1 Use of repeat sequence protein polymers in personal care compositions GENENCOR INTERNATIONAL, INC. 2005-06-30 US disclosed
WO-2005046710-A2 TGF-BETA BINDING AND SUPPORTED PEPTIDES GENENCOR INTERNATIONAL, INC. (US) 2005-05-26 WO disclosed
WO-2005046709-A2 TGF - BETA BINDING AND SUPPORTED PEPTIDES GENENCOR INTERNATIONAL, INC. (US) 2005-05-26 WO disclosed
WO-2005047314-A2 FGF-BETA BINDING AND SUPPORTED PEPTIDES GENENCOR INTERNATIONAL, INC. (US) 2005-05-26 WO disclosed
EP-1530637-A2 SUBTILISIN CARLSBERG PROTEINS WITH REDUCED IMMUNOGENICITY GENENCOR INTERNATIONAL, INC. (US) 2005-05-18 EP disclosed
CN-1612722-A Compositions comprising enzymes stabilized with certain osmoprotectants and methods of using such compositions for personal care PROCTER & GAMBLE (US) 2005-05-04 CN disclosed
CN-1612723-A Topical compositions comprising enzyme stabilized by inhibitor PROCTER & GAMBLE (US) 2005-05-04 CN disclosed
US-20050054843-A1 Subtilisin comprising b-cell epitope for use in detergents, textile treatment, liquid soaps, cosmetics and contact lense cleaning solutions GENECOR INTERNATIONAL, INC. 2005-03-10 US disclosed
WO-2005016302-A1 DUAL COMPONENT SKIN CARE COMPOSITIONS THAT COMPRISE A SELF-TANNING AGENT THE PROCTER & GAMBLE COMPANY (US) 2005-02-24 WO disclosed
WO-2005011643-A1 BILIQUID FOAMS, STABLE DISPERSIONS THEREOF AND A CORRESPONDING PROCESS OF MANUFACTURING DRUG DELIVERY SOLUTIONS LIMITED (GB) 2005-02-10 WO disclosed
EP-1461072-A4 PROTEASES PRODUCING AN ALTERED IMMUNOLOGICAL RESPONSE AND METHODS OF MAKING AND USING THE SAME GENENCOR INT (US) 2005-02-09 EP disclosed
US-6852815-B1 Hydrophobically-modified cationic tetrapolymer consisting essentially of the following monomers in wt. %; where: P is O or NR2; R1, R2, R3, R4 are independently H or C1-C5 alkyl; R5 is C2-C16 alkylene; and P is O or NR2; R1, R2, R3, R4 are ISP INVESTMENTS INC. (US) 2005-02-08 US disclosed
CN-1187378-C Ion-sensitive water-dispersible polymers, method for making same and items using same KIMBERLY CLARK CO (US) 2005-02-02 CN disclosed
WO-2005004833-A1 SELF-TANNING COMPOSITIONS COMPRISING A WATER-SOLUBLE VITAMIN B3 COMPOUND AND AN ALPHA-HYDROXYCARBONYL SELF-TANNING AGENT COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2005-01-20 WO disclosed
US-20050002978-A1 Cosmetic kits; multicompartment; storage stability THE PROCTER & GAMBLE COMPANY 2005-01-06 US disclosed
EP-1493430-A1 Self-tanning compositions comprising a water-soluble vitamin B3 compound and an alpha-hydroxycarbonyl self-tanning agent THE PROCTER & GAMBLE COMPANY (US) 2005-01-05 EP disclosed
EP-1493429-A1 Dual component skin care compositions that comprise a self-tanning agent The Procter & Gamble Company (US) 2005-01-05 EP disclosed
WO-2004105721-A1 STABLE COSMETIC COMPOSITIONS COMPRISING A SELF-TANNING AGENT THE PROCTER & GAMBLE COMPANY (US) 2004-12-09 WO disclosed
US-20040241113-A1 Stable cosmetic composition comprising a self-tanning agent PROCTER & GAMBLE COMPANY, THE 2004-12-02 US disclosed
EP-1481663-A1 Stable cosmetic compositions comprising a self-tanning agent THE PROCTER & GAMBLE COMPANY (US) 2004-12-01 EP disclosed
EP-1481664-A1 Stable cosmetic compositions comprising a self-tanning agent THE PROCTER & GAMBLE COMPANY (US) 2004-12-01 EP disclosed
WO-2004100905-A2 COSMETIC COMPOSITIONS FOR SKIN THE PROCTER & GAMBLE COMPANY (US) 2004-11-25 WO disclosed
US-20040223928-A1 Cosmetic compositions for skin THE PROCTER & GAMBLE COMPANY 2004-11-11 US disclosed
US-6815502-B1 FORMULATION OF TERPOLYMER OF ACRYLIC ACID, BUTYL ACRYLATE AND 2-ETHYLHEXYL ACRYLATE AND NON-CROSSLINKING ETHYLENE-VINYL ACETATE COPOLYMER; INSOLUBLE IN NEUTRAL MONOVALENT SALT SOLUTION, DISPERSIBLE IN WATER CONTAINING MULTIVALENT IONS KIMBERLY-CLARK WORLDWIDE, INC. 2004-11-09 US disclosed
US-6814974-B2 THE ION-SENSITIVE SULFONATE ANION MODIFIED ACRYLIC ACID COPOLYMERS KIMBERLY-CLARK WORLDWIDE, INC. 2004-11-09 US disclosed
EP-1461072-A1 PROTEASES PRODUCING AN ALTERED IMMUNOLOGICAL RESPONSE AND METHODS OF MAKING AND USING THE SAME GENENCOR INTERNATIONAL, INC. (US) 2004-09-29 EP disclosed
WO-2004080426-A2 USE OF REPEAT SEQUENCE PROTEIN POLYMERS IN PERSONAL CARE COMPOSITIONS DOW CORNING CORPORATION (US) 2004-09-23 WO disclosed
US-20040180027-A1 Use of repeat sequence protein polymers in personal care compositions DANISCO US INC. 2004-09-16 US disclosed
EP-1446090-A2 COMPOSITIONS CONTAINING ENZYMES STABILIZED WITH CERTAIN OSMO-PROTECTANTS AND METHODS FOR USING SUCH COMPOSITIONS IN PERSONAL CARE THE PROCTER & GAMBLE COMPANY (US) 2004-08-18 EP disclosed
EP-1446096-A1 TOPICAL COMPOSITIONS CONTAINING ENZYMES STABILISED WITH INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 2004-08-18 EP disclosed
WO-2004032894-A1 COSMETIC COMPOSITIONS WITH REDUCED TACK THE PROCTER & GAMBLE COMPANY (US) 2004-04-22 WO disclosed
US-20040071651-A1 Cosmetic compositions with reduced tack THE PROCTER & GAMBLE COMPANY 2004-04-15 US disclosed
US-6713414-B1 Ion-sensitive, water-dispersible polymers, a method of making same and items using same KIMBERLY-CLARK WORLDWIDE, INC. 2004-03-30 US disclosed
US-6683143-B1 COPOLYMER COMPRISING ACRYLAMIDO- 2-METHYL-1-PROPANESULFONIC ACID OR SODIUM SALT, (METH)ACRYLIC ACID, AND ALKYL ACRYLATE MONOMERS; DISPOSABLE PRODUCTS; DIAPERS KIMBERLY CLARK WORLDWIDE, INC. 2004-01-27 US disclosed
EP-1373296-A2 PROTEINS PRODUCING AN ALTERED IMMUNOGENIC RESPONSE AND METHODS OF MAKING AND USING THE SAME GENENCOR INTERNATIONAL, INC. (US) 2004-01-02 EP disclosed
US-6653406-B1 Blending sulfonate anion modified acrylic acid-based polymer and non- crosslinking poly(ethylene-vinyl acetate); binders for diapers and sanitary napkins KIMBERLY CLARK WORLDWIDE, INC. 2003-11-25 US disclosed
US-20030211068-A1 Cosmetic method THE PROCTER & GAMBLE COMPANY (US) 2003-11-13 US disclosed
CN-1455661-A Novel cosmetic, personal care, detergent and nutritional supplement compositions containing bioactive glass and methods of making and using the same SCHOTT GLAS (DE) 2003-11-12 CN disclosed
US-20030206896-A1 Cosmetic method THE PROCTER & GAMBLE COMPANY 2003-11-06 US disclosed
US-20030206897-A1 Cosmetic compositions THE PROCTER & GAMBLE COMPANY 2003-11-06 US disclosed
CN-1444607-A Ion-sensitive water-dispersible polymers, method for making same and items using same KIMBERLY CLARK CO (US) 2003-09-24 CN disclosed
US-20030175232-A1 Compositions containing enzymes stabilized with certain osmo-protectants and methods for using such compositions in personal care THE PROCTER & GAMBLE COMPANY 2003-09-18 US disclosed
WO-2003072746-A2 SUBTILISIN CARLSBERG PROTEINS WITH REDUCED IMMUNOGENICITY GENENCOR INTERNATIONAL, INC. (US) 2003-09-04 WO disclosed
US-20030157088-A1 Compositions containing enzymes stabilized with inhibitors having certain binding properties and methods for using such compositions in personal care THE PROCTOR & GAMBLE COMPANY 2003-08-21 US disclosed
US-6602955-B2 Water-dispersible or flushable materials, polymers are insoluble in wetting composition comprising ions ofmonovalent salt solutions at a concentration from about 0.3% to 10%, but can be soluble in water or divalent salt solutions KIMBERLY-CLARK WORLDWIDE, INC. 2003-08-05 US disclosed
US-6599848-B1 For disposable products that disintegrate in landfills KIMBERLY-CLARK WORLDWIDE, INC. 2003-07-29 US disclosed
WO-2003057246-A1 PROTEASES PRODUCING AN ALTERED IMMUNOLOGICAL RESPONSE AND METHODS OF MAKING AND USING THE SAME GENENCOR INTERNATIONAL, INC. (US) 2003-07-17 WO disclosed
WO-2003057713-A2 PROTEASES PRODUCING AN ALTERED IMMUNOGENIC RESPONSE AND METHODS OF MAKING AND USING THE SAME GENENCOR INTERNATIONAL, INC. (US) 2003-07-17 WO disclosed
CN-1427906-A Ion-sensitive water-dispersible polymers, method of making same and product using same KIMBERLY CLARK CO (US) 2003-07-02 CN disclosed
US-20030118605-A1 Proteins producing an altered immunogenic response and methods of making and using the same PROCTER & GAMBLE COMPANY, THE 2003-06-26 US disclosed
US-6579570-B1 Spraying, coating or foaming mixtures of acrylic terpolymers, ethylene-vinyl acetate copolymer binders and wetting agents on natural or synthetic fiber webs to form cleaners or disposable products KIMBERLY-CLARK WORLDWIDE, INC. 2003-06-17 US disclosed
EP-1317249-A1 COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2003-06-11 EP disclosed
EP-1317248-A1 COSMETIC METHOD THE PROCTER & GAMBLE COMPANY (US) 2003-06-11 EP disclosed
EP-1317246-A1 COSMETIC METHOD THE PROCTER & GAMBLE COMPANY (US) 2003-06-11 EP disclosed
EP-1317250-A1 COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2003-06-11 EP disclosed
EP-1317247-A1 COSMETIC METHOD FOR TREATMENT OF SKIN AND/OR HAIR THE PROCTER & GAMBLE COMPANY (US) 2003-06-11 EP disclosed
CN-1420760-A Cosmetic compositions PROCTER & GAMBLE (US) 2003-05-28 CN disclosed
CN-1420756-A Leave-on skin cosmetic compositions comprising polyhydric alcohol and liquid crystal forming emulsfier PROCTER & GAMBLE (US) 2003-05-28 CN disclosed
WO-2003041680-A1 TOPICAL COMPOSITIONS CONTAINING ENZYMES STABILIZED WITH INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 2003-05-22 WO disclosed
WO-2003041667-A2 COMPOSITIONS CONTAINING ENZYMES STABILIZED WITH CERTAIN OSMO-PROTECTANTS AND METHODS FOR USING SUCH COMPOSITIONS IN PERSONAL CARE THE PROCTER & GAMBLE COMPANY (US) 2003-05-22 WO disclosed
US-6548592-B1 Blend of sulfonate ion acrylic acid terpolymer and noncrosslinked ethylene-vinyl acetate copolymer; diapers, sanitary napkins, wipes KIMBERLY-CLARK WORLDWIDE, INC. 2003-04-15 US disclosed
EP-1272144-A2 NEW COSMETIC, PERSONAL CARE, CLEANING AGENT, AND NUTRITIONAL SUPPLEMENT COMPOSITIONS COMPRISING BIOACTIVE GLASS AND METHODS OF MAKING AND USING THE SAME Schott Glas (DE) 2003-01-08 EP disclosed
EP-1257252-A1 COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2002-11-20 EP disclosed
WO-2002077187-A2 PROTEINS PRODUCING AN ALTERED IMMUNOGENIC RESPONSE AND METHODS OF MAKING AND USING THE SAME GENENCOR INTERNATIONAL, INC. (US) 2002-10-03 WO disclosed
US-6444214-B1 COSMETIC MIXTURE KIMBERLY-CLARK WORLDWIDE, INC. 2002-09-03 US disclosed
EP-1227783-A1 LEAVE-ON SKIN COSMETIC COMPOSITIONS COMPRISING A POLYHYDRIC ALCOHOL AND A LIQUID CRYSTAL FORMING EMULSIFIER THE PROCTER & GAMBLE COMPANY (US) 2002-08-07 EP disclosed
EP-1227790-A1 COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2002-08-07 EP disclosed
US-6429261-B1 COPOLYMER OF ACRYLIC ACID, ACRYLATES, AND SODIUM 2-ACYRYL-AMIDO-2-METHYL PROPANESULFONATE WITH ETHYLENE-VINYL ACETATE COPOLYMER; WATER SOLUBILITY CHANGES WITH ION TYPE AND CONCENTRATION KIMBERLY-CLARK WORLDWIDE, INC. 2002-08-06 US disclosed
US-20020086039-A1 As preservative SCHOTT AG (DE) 2002-07-04 US disclosed
WO-2002022102-A1 COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2002-03-21 WO disclosed
WO-2002022100-A1 COSMETIC METHOD THE PROCTER & GAMBLE COMPANY (US) 2002-03-21 WO disclosed
WO-2002022099-A1 COSMETIC METHOD FOR TREATMENT OF SKIN AND/OR HAIR THE PROCTER & GAMBLE COMPANY (US) 2002-03-21 WO disclosed
WO-2002022101-A1 COSMETIC METHOD THE PROCTER & GAMBLE COMPANY (US) 2002-03-21 WO disclosed
WO-2002022103-A1 COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2002-03-21 WO disclosed
US-6319491-B1 COMPOSITION COMPRISING DENATURED ETHYL ALCOHOL, HYDROPHOBIC SILICA, MONOETHYL ESTER OF COPOLYMER OF METHYL VINYL ETHER AND MALEIC ANHYDRIDE, ISO-OCTAHEXACONTANE, OCTAMETHYLCYCLOTETRASILOXANE AND HYDROXYPROPYL CELLUOSE WHIPPLE MICHAEL B (US) 2001-11-20 US disclosed
US-6319491-B1 COMPOSITION COMPRISING DENATURED ETHYL ALCOHOL, HYDROPHOBIC SILICA, MONOETHYL ESTER OF COPOLYMER OF METHYL VINYL ETHER AND MALEIC ANHYDRIDE, ISO-OCTAHEXACONTANE, OCTAMETHYLCYCLOTETRASILOXANE AND HYDROXYPROPYL CELLUOSE WHIPPLE MICHAEL B (US) 2001-11-20 US disclosed
EP-1152746-A1 COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2001-11-14 EP disclosed
EP-1152747-A2 LEAVE-ON COSMETIC COMPOSITIONS CONTAINING A CATIONIC POLYMER THE PROCTER & GAMBLE COMPANY (US) 2001-11-14 EP disclosed
WO-2001072262-A2 NEW COSMETIC, PERSONAL CARE, CLEANING AGENT, AND NUTRITIONAL SUPPLEMENT COMPOSITIONS COMPRISING BIOACTIVE GLASS AND METHODS OF MAKING AND USING THE SAME SCHOTT GLAS (DE) 2001-10-04 WO disclosed
WO-2001034100-A1 LEAVE-ON SKIN COSMETIC COMPOSITIONS COMPRISING A POLYHYDRIC ALCOHOL AND A LIQUID CRYSTAL FORMING EMULSIFIER THE PROCTER & GAMBLE COMPANY (US) 2001-05-17 WO disclosed
WO-2001034111-A1 COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2001-05-17 WO disclosed
EP-1051149-A1 COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2000-11-15 EP disclosed
WO-2000048569-A1 COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2000-08-24 WO disclosed
WO-2000048555-A2 LEAVE-ON COSMETIC COMPOSITIONS CONTAINING A CATIONIC POLYMER THE PROCTER & GAMBLE COMPANY (US) 2000-08-24 WO disclosed
WO-2000048568-A1 COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2000-08-24 WO disclosed
EP-1005322-A1 WEAR RESISTANT COSMETICS AVON PRODUCTS, INC. (US) 2000-06-07 EP disclosed
EP-1005322-A4 WEAR RESISTANT COSMETICS AVON PROD INC (US) 2000-06-07 EP disclosed
WO-1999038485-A1 COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1999-08-05 WO disclosed
WO-1999038486-A1 COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1999-08-05 WO disclosed
US-5919467-A BRANCHED CHAIN ALIPHATIC HYDROCARBON, POLYETHYLENE PARTICLES, CROSSLINKED ACRYLATE POLYMER, ALKYLMETHYLSILOXANE THE PROCTOR & GAMBLE COMPANY (US) 1999-07-06 US disclosed
WO-1998042298-A1 WEAR RESISTANT COSMETICS AVON PRODUCTS, INC. (US) 1998-10-01 WO disclosed
EP-0785763-A4 1997-07-30 EP disclosed
EP-0785763-A1 POWDER COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1997-07-30 EP disclosed
EP-0752845-A4 POWDER COSMETIC COMPOSITIONS PROCTER & GAMBLE (US) 1997-03-19 EP disclosed
EP-0752845-A1 POWDER COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1997-01-15 EP disclosed
WO-1996015760-A1 COSMETIC COMPOSITIONS IN STICK FORM THE PROCTER & GAMBLE COMPANY (US) 1996-05-30 WO disclosed
WO-1996015762-A1 COSMETIC COMPOSITIONS IN STICK FORM THE PROCTER & GAMBLE COMPANY (US) 1996-05-30 WO disclosed
WO-1996015761-A1 COSMETIC COMPOSITIONS IN STICK FORM THE PROCTER & GAMBLE COMPANY (US) 1996-05-30 WO disclosed
EP-0500423-B1 Cleansing composition containing synthetic oil and method for carrying it out OREAL (FR) 1996-01-24 EP disclosed
WO-1995025503-A1 POWDER COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1995-09-28 WO disclosed
WO-1995025499-A1 POWDER COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1995-09-28 WO disclosed
EP-0498716-B1 Cleansing composition OREAL (FR) 1995-02-08 EP disclosed
EP-0498716-B1 Cleansing composition OREAL (FR) 1995-02-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (42 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160136082-A1 Cosmetic Compositions Having Persistent Tightening Effects CUTA, ACR, MMAB OPRM1 4659/4885TSHR 3055/4885THRB 2548/4885
US-20070224138-A1 Cosmetic composition comprising gingko biloba and sunscreen agents DGKB, GLA, DSG1 OPRM1 4628/4885TSHR 4799/4885THRB 2426/4885
US-20050203026-A1 Rosacea; vascular endothelial growth factor inhibitors; protease inhibitors such as Bowman-Birk Inhibitor, soybean trypsin inhibitor, and Eglin chymotrypsin inhibitor FLT1, SERPINB1, TEK OPRM1 4566/4885TSHR 3821/4885THRB 2480/4885
US-20030118605-A1 Proteins producing an altered immunogenic response and methods of making and using the same HLA-DRB1, CD74, TSG101 OPRM1 4304/4885TSHR 4424/4885THRB 4651/4885
US-20060088486-A1 Topical use of post-application expanding cosmetic composition CUTA, PLIN5, MITF OPRM1 4142/4885TSHR 1533/4885THRB 3461/4885
US-20050148059-A1 Protease producing an altered immunogenic response and methods of making and using the same TMPRSS15, CMA1, CPA3 OPRM1 4783/4885TSHR 4667/4885THRB 4856/4885
US-20030175232-A1 Compositions containing enzymes stabilized with certain osmo-protectants and methods for using such compositions in personal care TREH, CUTA, LPO OPRM1 3064/4885TSHR 3649/4885THRB 3602/4885
US-10682383-B2 Personal care compositions with improved hyposensitivity CUTA, DPM1, PIEZO1 OPRM1 3922/4885TSHR 3458/4885THRB 986/4885
US-20060002876-A1 Personal care compositions with improved hyposensitivity CUTA, DPM1, PIEZO1 OPRM1 3922/4885TSHR 3458/4885THRB 986/4885
US-20080113917-A1 Tgfbeta Supported and Binding Peptides TGFBR1, TGFBR2, TGFB1 OPRM1 2591/4885TSHR 1734/4885THRB 212/4885
US-20090098170-A1 COSMETIC COMPOSITION COMPRISING SOLID ENTRAPPING PARTICLES FOR SUSTAINED RELEASE OF VOLATILE MATERIALS SAMM50, CUTA, TRPA1 OPRM1 64/4885TSHR 3172/4885THRB 4357/4885
US-20050002978-A1 Cosmetic kits; multicompartment; storage stability CUTA, MITF, TREH OPRM1 4859/4885TSHR 3553/4885THRB 3608/4885
US-20070224229-A1 Cosmetic composition comprising Seabuckthorn CUTA, DHCR24, AQP3 OPRM1 4753/4885TSHR 3873/4885THRB 4256/4885
US-20090060933-A1 PROTEASES PRODUCING AN ALTERED IMMUNOGENIC RESPONSE AND METHODS OF MAKING AND USING THE SAME TMPRSS15, CMA1, MASP2 OPRM1 4788/4885TSHR 4635/4885THRB 4848/4885
US-20030211068-A1 Cosmetic method CUTA, VNN1, GLA OPRM1 4768/4885TSHR 3134/4885THRB 2492/4885
US-20060093571-A1 Hair and skin protecting compositions based on esters or ethers of betulin BET1, CUTA, EBP OPRM1 4393/4885TSHR 2976/4885THRB 634/4885
US-20050202551-A1 Proteins producing an altered immunogenic response and methods of making and using the same HLA-DRB1, CD74, TSG101 OPRM1 4304/4885TSHR 4424/4885THRB 4651/4885
US-20050054843-A1 Subtilisin comprising b-cell epitope for use in detergents, textile treatment, liquid soaps, cosmetics and contact lense cleaning solutions SSB, CUTA, DSG1 OPRM1 4815/4885TSHR 4175/4885THRB 4731/4885
US-20120270932-A1 Personal Care Compositions with Improved Hyposensitivity CUTA, DPM1, PIEZO1 OPRM1 3922/4885TSHR 3458/4885THRB 986/4885
US-20120014885-A1 Personal Care Compositions and Methods for Their Use CUTA, VEGFA, BDNF OPRM1 3996/4885TSHR 2993/4885THRB 1520/4885
US-20060147399-A1 Non-pressurized post-application expanding composition NONO, SMURF1, SMURF2 OPRM1 4676/4885TSHR 3854/4885THRB 4438/4885
US-20030206897-A1 Cosmetic compositions MMP1, CUTA, MMP2 OPRM1 2668/4885TSHR 3690/4885THRB 3134/4885
US-20130195781-A1 Modified Variant Bowman Birk Protease Inhibitors SERPINB1, BBC3, BRAP OPRM1 4739/4885TSHR 4485/4885THRB 4367/4885
US-20040223928-A1 Cosmetic compositions for skin CUTA, TYR, GLA OPRM1 4771/4885TSHR 3926/4885THRB 4601/4885
US-20110230405-A1 Peptides and Supported Peptides for Treating Skin Diseases VEGFA, FLT1, KDR OPRM1 3883/4885TSHR 2984/4885THRB 1950/4885
US-20100093028-A1 comprise peptides that bind target proteins, and that are further modified to have greater protease inhibitory activity and/or be produced at greater yields than the unmodified BBPIs; has a greater trypsin inhibitory activity; used in personal care CPB1, SERPINB1, PNKP OPRM1 4434/4885TSHR 3172/4885THRB 2332/4885
US-20040071651-A1 Cosmetic compositions with reduced tack CUTA, DSG1, LIPA OPRM1 4877/4885TSHR 3760/4885THRB 3514/4885
US-20100092409-A1 PERSONAL CARE COMPOSITIONS COMPRISING MODIFIED VARIANT BOWMAN BIRK PROTEASE INHIBITORS SERPINB1, CPB1, HABP2 OPRM1 4801/4885TSHR 4419/4885THRB 4237/4885
US-20030157088-A1 Compositions containing enzymes stabilized with inhibitors having certain binding properties and methods for using such compositions in personal care CUTA, LCT, TYR OPRM1 4682/4885TSHR 4356/4885THRB 3318/4885
US-20030206896-A1 Cosmetic method MMP13, MMP3, MMP1 OPRM1 4515/4885TSHR 3172/4885THRB 4457/4885
US-20060002868-A1 Coloring skin with a mixture of a water-soluble vitamin B3 compound and an alpha-hydroxyaldehyde self-tanning agent (dihydroxyacetone, erythrulose); more even skin coloring ADH1B, TYR, ADH4 OPRM1 4793/4885TSHR 3862/4885THRB 776/4885
US-20040241113-A1 Stable cosmetic composition comprising a self-tanning agent CUTA, TREH, POLR1C OPRM1 4409/4885TSHR 3000/4885THRB 3817/4885
US-20050238607-A1 FGF-5 supported and binding peptides FGF1, FGF2, IGFBP5 OPRM1 4196/4885TSHR 704/4885THRB 1286/4885
US-20050202552-A1 Proteins producing an altered immunogenic response and methods of making and using the same HLA-DRB1, CD74, TSG101 OPRM1 4304/4885TSHR 4424/4885THRB 4651/4885
US-20190111095-A1 Personal Care Compositions With Improved Hyposensitivity CUTA, DPM1, PIEZO1 OPRM1 3922/4885TSHR 3458/4885THRB 986/4885
US-10183051-B2 Personal care compositions with improved hyposensitivity CUTA, DPM1, PIEZO1 OPRM1 3922/4885TSHR 3458/4885THRB 986/4885
US-20130202546-A1 Cosmetic Compositions Having Persistent Tightening Effects CUTA, ACR, MMAB OPRM1 4659/4885TSHR 3055/4885THRB 2548/4885
US-20170128512-A1 Personal Care Compositions With Improved Hyposensitivity CUTA, DPM1, PIEZO1 OPRM1 3922/4885TSHR 3458/4885THRB 986/4885
US-20130065829-A1 PEPTIDES AND SUPPORTED PEPTIDES FOR TREATING SKIN DISEASES VEGFA, FLT1, KDR OPRM1 3883/4885TSHR 2984/4885THRB 1950/4885
US-20110076260-A1 Proteases Producing an Altered Immunogenic Response and Methods of Making and Using the Same TMPRSS15, CMA1, MASP2 OPRM1 4788/4885TSHR 4635/4885THRB 4848/4885
US-20080269139-A1 FGF-5 Supported and Binding Peptides FGF1, FGF2, IGFBP5 OPRM1 4196/4885TSHR 704/4885THRB 1286/4885
US-20150174094-A1 Personal Care Compositions With Improved Hyposensitivity CUTA, DPM1, PIEZO1 OPRM1 3922/4885TSHR 3458/4885THRB 986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.